{'fraction_non_alphanumeric': 0.013562386980108499, 'fraction_numerical': 0.0, 'mean_word_length': 5.049180327868853, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 6, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
MONITORING DOSE-LENGTH PRODUCT IN COMPUTED TOMOGRAPHY OF THE CHEST CONSIDERING SEX AND BODY WEIGHT.

Dose-length product (DLP) is widely used as an indicator of the radiation dose in computed tomography. The aim of this study was to investigate the significance of sex and body weight in DLP-based monitoring of the radiation dose. Eight hundred computed tomographies of the chest performed using four different scanners were analysed. The DLP was compared with body weight by linear regression in men and women separately. The DLP was positively correlated with body weight, and dependence on sex and weight differed among scanners. Standard DLP values adjusted for sex and weight facilitated interscanner comparison of the radiation dose and its dependence on sex and weight. Adjusting the DLP for sex and weight allowed one to identify examinations with possibly excessive doses independently of weight. Monitoring the DLP in relation to sex and body weight appears to aid detailed comparison of the radiation dose among imaging protocols and scanners and daily observations to find unexpected variance.